2min chapter

Breakpoints cover image

#75 – Breakpoints Talks Breakpoints: Aminoglycosides

Breakpoints

CHAPTER

Pseudomonas and Aminoglycosides: A Comparison

Pip Tengza: I think what happened with pseudo maybe arguably is even more controversial. The changes with Pseudomonas are more drastic and really clinicians need to know what's up with this, he says. "The take home from the M100 for 2023 from CLS side that will most blow people's minds," Pang added.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode